Aethlon Medical, Inc. (NASDAQ:AEMD)
Industry: Healthcare

OFF LIST - 1918 consecutive market days: OFF LIST as of 10/21/2008 Through 11/14/2016

Aethlon Medical, Inc., a medical technology company, focuses on addressing unmet needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.

Current Quote*
Last: $2.544
Change: -0.056
Book: $20.625
Volume: 3,884,601

As Of: 01/22 13:01 ET
*Quotes delayed by 20min.

Graphs for AEMD

3 Month Graph

6 Month Graph

1 Year Graph